English | Español
Patient Daily | Dec 9, 2025

Protego Biopharma raises $130M series B for pivotal amyloidosis drug trial
Patient Daily | Dec 9, 2025

Building next-generation biologics relies on AI integration and automation advances
Patient Daily | Dec 9, 2025

FDA extends review period for Ascendis Pharma's dwarfism drug TransCon CNP
Patient Daily | Dec 9, 2025

Regeneron partners with Tessera Therapeutics on gene editing therapy for AATD
Patient Daily | Dec 9, 2025

FDA’s advanced manufacturing designation may ease mid-development process changes for cell therapies
Patient Daily | Dec 9, 2025

Lilly reduces Zepbound prices amid ongoing competition with Novo Nordisk
Patient Daily | Dec 9, 2025

FDA official links child deaths to COVID-19 vaccines and proposes stricter review process
Patient Daily | Dec 9, 2025

Study finds rising rates of adolescent noise-induced hearing damage by age eighteen

Trending
+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+ Regulatory
A. R. Baird | Jun 15, 2026

Health care reform group launches campaign linking consolidation to rising costs
+ Pharmaceuticals
Patient Daily | Jun 16, 2026

Intellia gene editing therapy shows strong results in hereditary angioedema study
+ Pharmaceuticals
Patient Daily | Jun 17, 2026

PwC reports strong biopharma M&A activity as sector shifts to precision science